Titan Cement (TITC) | Financial Analysis & Statements
Titan Cement International S.A. | Large-cap | Basic Materials
Titan Cement International S.A. | Large-cap | Basic Materials
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
2.6B
Gross Profit
701.9M
26.54%
Operating Income
412.8M
15.61%
Net Income
290.3M
10.98%
EPS (Diluted)
€3.89
Balance Sheet Metrics
Total Assets
3.3B
Total Liabilities
1.5B
Shareholders Equity
1.8B
Debt to Equity
0.80
Cash Flow Metrics
Operating Cash Flow
278.2M
Free Cash Flow
202.2M
Revenue & Profitability Trend
Titan Cement Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.6B | 2.5B | 2.3B | 1.7B | 1.6B |
| Cost of Goods Sold | 1.9B | 1.9B | 1.9B | 1.4B | 1.3B |
| Gross Profit | 701.9M | 641.9M | 392.7M | 310.9M | 309.3M |
| Operating Expenses | 297.5M | 252.7M | 218.0M | 180.9M | 168.2M |
| Operating Income | 412.8M | 395.2M | 179.2M | 132.1M | 143.5M |
| Pre-tax Income | 375.6M | 339.7M | 137.2M | 108.4M | 36.9M |
| Income Tax | 85.3M | 67.1M | 26.7M | 16.8M | 35.8M |
| Net Income | 290.3M | 272.6M | 110.5M | 91.6M | 1.2M |
| EPS (Diluted) | €3.89 | €3.59 | €1.44 | €1.22 | €0.01 |
Income Statement Trend
Titan Cement Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 950.5M | 1.0B | 812.2M | 634.0M | 665.6M |
| Non-Current Assets | 2.3B | 2.2B | 2.2B | 2.0B | 2.0B |
| Total Assets | 3.3B | 3.2B | 3.0B | 2.7B | 2.7B |
| Liabilities | |||||
| Current Liabilities | 537.5M | 846.1M | 573.8M | 440.8M | 545.2M |
| Non-Current Liabilities | 920.5M | 785.7M | 996.2M | 900.9M | 855.6M |
| Total Liabilities | 1.5B | 1.6B | 1.6B | 1.3B | 1.4B |
| Equity | |||||
| Total Shareholders Equity | 1.8B | 1.6B | 1.4B | 1.3B | 1.3B |
Balance Sheet Composition
Titan Cement Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 290.3M | 272.6M | 110.5M | 91.6M | 1.2M |
| Operating Cash Flow | 278.2M | 256.9M | -45.2M | 32.0M | 52.7M |
| Investing Activities | |||||
| Capital Expenditures | -231.7M | -208.0M | -228.8M | -110.2M | -73.7M |
| Investing Cash Flow | -248.6M | -214.9M | -230.1M | -109.9M | -74.4M |
| Financing Activities | |||||
| Dividends Paid | -63.4M | -45.0M | -38.6M | -32.0M | -17.6M |
| Financing Cash Flow | -202.4M | -73.3M | 72.6M | -180.5M | -29.0M |
| Free Cash Flow | 202.2M | 225.6M | 2.1M | 92.5M | 215.1M |
Cash Flow Trend
Titan Cement Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
9.97
Price to Book
1.41
Price to Sales
1.08
PEG Ratio
1.23
Profitability Ratios
Profit Margin
10.55%
Operating Margin
12.50%
Return on Equity
15.09%
Return on Assets
7.84%
Financial Health
Current Ratio
2.62
Debt to Equity
33.45
Beta
0.89
Per Share Data
EPS (TTM)
€3.88
Book Value per Share
€27.49
Revenue per Share
€35.82
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| titc | 2.9B | 9.97 | 1.41 | 15.09% | 10.55% | 33.45 |
| Anheuser-Busch InBev | 120.4B | 21.06 | 1.57 | 6.60% | 11.75% | 81.53 |
| Syneos Health | 6.9B | 377.86 | 1.03 | -1.38% | -1.59% | 28.51 |
| Azelis Group NV | 3.2B | 17.86 | 1.12 | 6.77% | 4.29% | 63.15 |
| Solvay SA | 3.1B | 15.83 | 2.26 | 14.16% | 3.88% | 155.68 |
| Tessenderlo Group NV | 1.5B | 35.71 | 0.80 | 2.28% | 1.62% | 13.46 |
Financial data is updated regularly. All figures are in the company's reporting currency.